GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy

To identify novel epilepsy genes using a panel approach and describe the functional consequences of mutations.

[1]  S. Kim.  Authorship , 2016, Korean journal of family medicine.

[2]  M. Gill,et al.  Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders , 2014, Molecular Psychiatry.

[3]  U. Stephani,et al.  Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes , 2013, Nature Genetics.

[4]  Anne de Saint Martin,et al.  GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction , 2013, Nature Genetics.

[5]  J. Shendure,et al.  GRIN2A mutations cause epilepsy-aphasia spectrum disorders , 2013, Nature Genetics.

[6]  Michael R. Johnson,et al.  De novo mutations in the classic epileptic encephalopathies , 2013, Nature.

[7]  Qiang Zhou,et al.  NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease , 2013, Nature Reviews Neuroscience.

[8]  R. Gerardy-Schahn,et al.  West syndrome caused by ST3Gal‐III deficiency , 2013, Epilepsia.

[9]  De novo mutations in epileptic encephalopathies , 2013 .

[10]  J. Hebebrand,et al.  Behavioral phenotype in five individuals with de novo mutations within the GRIN2B gene , 2013, Behavioral and Brain Functions.

[11]  Bradley P. Coe,et al.  Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.

[12]  B. V. van Bon,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.

[13]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.

[14]  S. Gallati,et al.  Targeted next generation sequencing as a diagnostic tool in epileptic disorders , 2012, Epilepsia.

[15]  S. Schachter,et al.  The NMDA receptor complex as a therapeutic target in epilepsy: a review , 2011, Epilepsy & Behavior.

[16]  J. Rosenfeld,et al.  Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic function , 2011, European Journal of Human Genetics.

[17]  L. DeLisi,et al.  Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia , 2011, Translational Psychiatry.

[18]  M. Rieder,et al.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations , 2011, Nature Genetics.

[19]  P. Paoletti.  Molecular basis of NMDA receptor functional diversity , 2011, The European journal of neuroscience.

[20]  H. Ropers,et al.  Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes , 2010, Nature Genetics.

[21]  H. Bading,et al.  Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders , 2010, Nature Reviews Neuroscience.

[22]  M. Komada,et al.  Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay. , 2010, American journal of human genetics.

[23]  J. H. Cross,et al.  Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009 , 2010, Epilepsia.

[24]  J. R. Geiger,et al.  Potentiation of Glycine-Gated NR1/NR3A NMDA Receptors Relieves Ca2+-Dependent Outward Rectification , 2009, Front. Mol. Neurosci..

[25]  T. Skotland,et al.  contributed equally to this work. , 2010 .

[26]  H. Sugerman,et al.  Association between Incident Cancer and Subsequent Stroke , 2015, Annals of neurology.

[27]  L. Lagae,et al.  Microdeletions involving the SCN1A gene may be common in SCN1A‐mutation‐negative SMEI patients , 2006, Human mutation.

[28]  E. Gouaux,et al.  Subunit arrangement and function in NMDA receptors , 2005, Nature.

[29]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[30]  J. Stephenson.  Epileptic Syndromes in Infancy, Childhood and Adolescence , 2004 .

[31]  E. Haan,et al.  Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation. , 2003, American journal of human genetics.

[32]  I. Scheffer,et al.  Infantile spasms, dystonia, and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene, ARX , 2002, Brain and Development.

[33]  H. Betz,et al.  Evidence for a Tetrameric Structure of Recombinant NMDA Receptors , 1998, The Journal of Neuroscience.

[34]  H. Hirai,et al.  Molecular Determinants of Agonist Discrimination by NMDA Receptor Subunits: Analysis of the Glutamate Binding Site on the NR2B Subunit , 1997, Neuron.